FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

http://www.fda.gov/files/drugs/published/ProliaDSC.11.22.2022.mp3http://www.fda....

Source: FDA Drug Safety Podcasts - December 16, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts